Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis

Journal of Bone and Mineral Research

Volumn 11, Issue 8, 1996, Pages 1043-1051

  Pacifici, Roberto ^a  

^a BARNES JEWISH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; ESTROGEN;

BONE METABOLISM; ESTROGEN METABOLISM; HUMAN; OSTEOCLAST; OSTEOLYSIS; PATHOPHYSIOLOGY; POSTMENOPAUSE OSTEOPOROSIS; REVIEW;

EID: 0029783770     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbmr.5650110802     Document Type: Review

References (99)

1. Gowen M, Wood DD, Ihrie EJ, McGuire MKB, Russell RGG 1983 An interleukin-1-like factor stimulates bone resorption in vitro. Nature 306:378-380.
2. Lorenzo JA, Sousa SL, Alander C, Raisz LG, Dinarello CA 1987 Comparison of the bone-resorbing activity in the supernatants from phytohemaglutinin-stimulated human peripheral blood mononuclear cells with that of cytokines through the use of an antiserum to interleukin 1. Endocrinology 121:1164-1170.
3. Gowen M, Wood DD, Russell RGG 1985 Stimulation of the proliferation of human bone cells in vitro by human monocyte products with interleukin-1 activity. J Clin Invest 75:1223-1229.
4. Canalis E 1986 Interleukin-1 has independent effects on deoxyribonucleic acid and collagen synthesis in cultures of rat calvariae. Endocrinology 118:74-81.
5. Stashenko P, Dewhirst FE, Rooney ML, Desjardins LA, Heeley JD 1987 Interleukin-1 β is a potent inhibitor of bone formation in vitro. J Bone Miner Res 2:559-565.
6. Girasole G, Jilka RL, Passeri G, Boswell S, Boder G, Williams DC, Manolagas SC 1992 17β-estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: A potential mechanism for the antiosteoporotic effect of estrogens. J Clin Invest 89:883-891.
7. Jilka RL, Hangoc G, Girasole G, Passeri G, Williams DC, Abrams JS, Boyce B, Broxmeyer H, Manolagas SC 1992 Increased osteoclast development after estrogen loss: Mediation by interleukin-6. Science 257:88-91.
8. Passeri G, Girasole G, Jilka RL, Manolagas SC 1993 Increased interleukin-6 production by murine bone marrow and bone cells after estrogen withdrawal. Endocrinology 133:822-828.
9. Bertolini DR, Nedwin GE, Bringman TS, Smith DD, Mundy GR 1986 Stimulation of bone resorption and inhibition of bone formation in vitro by human tumor necrosis factor. Nature 319:516-518.
10. Thomson BM, Mundy GR, Chambers TJ 1987 Tumor necrosis factors α and β induce osteoblastic cells to stimulate osteoclastic bone resorption. J Immunol 138:775-779.
11. Takahashi N, Udagawa N, Akatsu T, Tanaka H, Shionome M, Suda T 1991 Role of colony-stimulating factors in osteoclast development. J Bone Miner Res 6:977-985.
12. Tanaka S, Takahashi N, Udagawa N, Tamura T, Akatsu T, Stanley ER, Kurokawa T, Suda T 1993 Macrophage colony-stimulating factor is indispensable for both proliferation and differentiation of osteoclast progenitors. J Clin Invest 91:257-263.
13. Schneider GB, Relfson M 1989 Pluripotent hemopoietic stem cells give rise to osteoclasts in vitro: Effect of rGM-CSF. Bone Miner 5:129-138.
14. Kurihara N, Suda T, Miura Y, Nakauchi H, Kodama H, Hiura K, Hakeda Y, Kumegawa M 1989 Generation of osteoclasts from isolated hematopoietic progenitor cells. Blood 74:1295-1302.
15. Nguyen L, Dewhirst FE, Hauschka PV, Stashenko P 1991 Interleukin-1β stimulates bone resorption and inhibits bone formation in vivo. Lymphokine Cytokine Res 10:15-21.
16. Boyce BF, Aufdemorte TB, Garrett IR, Yates AJP, Mundy GR 1989 Effects of interleukin-1 on bone turnover in normal mice. Endocrinology 125:1142-1150.
17. Sabatini M, Boyce B, Aufdemorte T, Bonewald L, Mundy GR 1988 Infusions of recombinant human interleukin 1 alpha and beta cause hypercalcemia in normal mice. Proc Natl Acad Sci USA 85:5235-5239.
18. Johnson RA, Boyce BF, Mundy GR, Roodman GD 1989 Tumors producing human tumor necrosis factor induce hypercalcemia and osteoclastic bone resorption in nude mice. Endocrinology 124:1424-1427.
19. Thomson BM, Saklatvala J, Chambers TJ 1986 Osteoblasts mediate interleukin 1 stimulation of bone resorption by rat osteoclasts. J Exp Med 164:104-112.
20. Hughes DE, Jilka RL, Manolagas S, Dallas SL, Bonewald LF, Mundy GR, Boyce BF 1995 Sex steroids promote osteoclast apoptosis in vitro and in vivo. J Bone Miner Res 10 (abstract 48).
21. Pfeilschifter J, Chenu C, Bird A, Mundy GR, Roodman GD 1989 Interleukin-1 and tumor necrosis factor stimulate the formation of human osteoclast-like cells in vitro. J Bone Miner Res 4:113-118.
22. Suda T, Takahashi N, Martin TJ 1992 Modulation of osteoclast differentiation. Endocrinol Rev 13:66-80.
23. Srivastava S, McHugh K, Kimble R, Ross FP, Pacifici R 1995 Estrogen down-regulates the expression of M-CSF mRNA in bone marrow stromal cells by stimulating the production of the transcription factor EGR-1. J Bone Miner Res 10 (Suppl 1): S18.
24. Elias JA, Lentz V 1990 IL-1 and tumor necrosis factor synergistically stimulate fibroblast IL-6 production and stabilize IL-6 messenger RNA. J Immunol 145:161-166.
25. Felix R, Fleish H, Elford PR 1989 Bone-resorbing cytokines enhance release of macrophage colony-stimulating activity by osteoblastic cell MC3T3-E1. Calcif Tissue Int 44:356-360.
26. Lorenzo JA, Souss SL, Fonseca JM, Hock JM, Medlock ES 1987 Colony-stimulating factors regulate the development of multinucleated osteoclasts from recently replicated cells in vitro. J Clin Invest 160:164-160.
27. Kurihara N, Civin C, Roodman GD 1991 Osteotropic factor responsiveness of highly purified populations of early and late precursors for human multinucleated cells expressing the osteoclast phenotype. J Bone Miner Res 6:257-261.
28. Roodman GD 1992 Interleukin-6: An osteotropic factor? J Bone Miner Res 7:475-478.
29. Tamura T, Udagawa N, Takahashi N, Miyaura C, Tanaka S, Yamada Y, Koishihara Y, Ohsugi Y, Kumaki K, Taga T, Kishimoto T, Suda T 1993 Soluble Interleukin-6 receptor triggers osteoclast formation by interleukin-6. Proc Natl Acad Sci USA 90:11924-11928.
30. Udagawa N, Takahashi N, Katagiri T, Tamura T, Wada S, Findlay DM, Martin TJ, Hirota H, Tada T, Kishimoto T, Suda T 1995 Interleukin (IL)-6 induction of osteoclast differentiation depends on IL-6 receptors expressed on osteoblastic cells but not on osteoclast progenitors. J Exp Med 182:1461-1468.
31. Lowik CWGM, Van der Plujim G, Bloys H, Hoekeman K, Bijvoet OLM, Aarden LA, Papapoulos SE 1993 Parathyroid hormone (PTH) and PTH-like protein (PLP) stimulate IL-6 production by osteogenic cells: A possible role of interleukin-6 in osteoclastogenesis. Biochem Biophys Res Commun 162: 1546-1552.
32. Kitazawa R, Kimble RB, Vannice JL, Kung VT, Pacifici R 1994 Interleukin-1 receptor antagonist and tumor necrosis factor binding protein decrease osteoclast formation and bone resorption in ovariectomized mice. J Clin Invest 94:2397-2406.
33. Kania DM, Binkley N, Checovich M, Havighurst T, Schilling M, Ershler WB 1995 Elevated plasma levels of interleukin-6 in postmenopausal women do not correlate with bone density. J Am Geriat Soc 43:236-239.
34. Woodroofe C, Muller W, Ruther U 1992 Long-term consequences of interleukin-6 overexpression in transgenic mice. DNA Cell Biol 11:587-592.
35. Felix R, Cecchini MG, Fleish H 1990 Macrophage colony-stimulating factor restores in vivo bone resorption in the op/op osteopetrotic mouse. Endocrinology 127:2592-2597.
36. Yoshida HS, Hayashi S, Kunisada T, Ogawa M, Nishikawa S, Okamura H, Sudo T, Schultz LD 1990 The murine mutation osteopetrosis is in the coding region of macrophage colony stimulating factor gene. Nature 345:442-444.
37. Macdonald BR, Mundy GR, Clark S, Wang EA, Kuehl TJ, Stanley ER, Roodman GD 1986 Effects of human recombinant CSF-GM and highly purified CSF-1 on the formation of multinucleated cells with osteoclast characteristics in long-term bone marrow cultures. J Bone Miner Res 1:227-232.
38. Kurihara N, Chenu C, Miller M, Civin C, Roodman GD 1990 Identification of committed mononuclear precursors for osteoclast-like cells formed in long term human marrow cultures. Endocrinology 126:2733-2741.
39. Matayoshi A, Brown C, DiPersio J, Haugh J, Kuestner R, Pacifici R 1995 Generation of human osteoclasts from peripheral blood cd 34+ cells. J Bone Miner Res 10 (abstract T298).
40. Dinarello CA 1991 Interleukin-1 and interleukin-1 antagonism. Blood 777:1627-1652.
41. Fibbe WE, Van Damme J, Billiau A, Goselink HM, Vogt PJ, Van Eeden PR, Altroch BW, Falkenburg JHF 1988 Intereleukin-1 induces human marrow stromal cells in long term cultures to produce G-CSF and M-CSF. Blood 71:431-435.
42. Rifas L, Kenney JS, Marcelli M, Pacifici R, Dawson LL, Cheng S, Avioli LV 1995 Production of interleukin-6 in human osteoblasts and human bone marrow stromal cells: Evidence that induction by interleukin-1 and tumor necrosis factor-a is not regulated by ovarian steroids. Endocrinology 136:4056-4067 (abstract).
43. Oursler MJ, Cortese C, Keeting P, Anderson MA, Bonde SK, Riggs BL, Speisberg TC 1991 Modulation of transforming growth factor-beta production in normal human osteoblast-like cells by 17 beta-estradiol and parathyroid hormone. Endocrinology 129:3313-3320.
44. Turner RT, Riggs BL, Spelsberg TC 1994 Skeletal effects of estrogen. Endocrine Rev 15:275-300.
45. Pacifici R, Rifas L, Teitelbaum S, Slatopolsky E, McCracken R, Bergfeld M, Lee W, Avioli LV, Peck WA 1987 Spontaneous release of interleukin 1 from human blood monocytes reflects bone formation in idiopathic osteoporosis. Proc Natl Acad Sci USA 84:4616-4620.
46. Pacifici R, Rifas L, McCracken R, Vered I, McMurtry C, Avioli LV, Peck WA 1989 Ovarian steroid treatment blocks a postmenopausal increase in blood monocyte interleukin 1 release. Proc Natl Acad Sci USA 86:2398-2402.
47. Pacifici R, Brown C, Rifas L, Avioli LV 1990 TNFα and GM-CSF secretion from human blood monocytes: Effect of menopause and estrogen replacement. J Bone Miner Res 5:145 (abstract).
48. Pacifici R, Vannice JL, Rifas L, Kimble RB 1993 Monocytic secretion of interleukin-1 receptor antagonist in normal and osteoporotic women: Effect of menopause and estrogen/progesterone therapy. J Clin Endocrinol Metab 77:1135-1141.
49. Pacifici R, Brown C, Puscheck E, Friedrich E, Slatopolsky E, Maggio D, McCracken R, Avioli LV 1991 Effect of surgical menopause and estrogen replacement on cytokine release from human blood mononuclear cells. Proc Natl Acad Sci USA 88:5134-5138.
50. Fiore CE, Falcidia E, Foti R, Motta M, Tamburino C 1993 Differences in the time course of the effects of oophorectomy in women on parameters of bone metabolism and interleukin-1 levels in the circulation. Bone Miner 20:79-85.
51. Horowitz M 1993 Cytokines and estrogen in bone: Anti-osteoporotic effects. Science 260:626-627.
52. Witsell AL, Schook LB 1991 Macrophage heterogeneity occurs through a developmental mechanism. Proc Natl Acad Sci USA 88:1963-1967.
53. Kimble RB, Vannice JL, Bloedow DC, Thompson RC, Hopfer W, Kung V, Brownfield C, Pacifici R 1994 Interleukin-1 receptor antagonist decreases bone loss and bone resorption in ovariectomized rats. J Clin Invest 93:1959-1967.
54. Pioli G, Girasole G, Pedrazzoni M, Sansoni P, Davoli L, Ciotti G, Mantovani A, Passeri M 1989 Spontaneous release of interleukin 1 (IL-1) from medullary mononuclear cells of Pagetic subjects. Calcif Tissue Int 45:257-259.
55. Choen-Solal ME, Graulet AM, Guerris J, Denne MA, Bergot C, Morieux C, sedel L, Kuntz D, de Vernejoul MC 1995 Bone resorption at the femoral neck is dependent on local factors in nonosteoporotic late postmenopausal women: An in vitro-in vivo study. J Bone Miner Res 10:307-314.
56. Bismar H, Diel I, Ziegler R, Pfeilschifter J 1995 Increased cytokine secretion by human marrow cells after menopause or discontinuation of estrogen replacement. J Clin Endocrinol Metab 80:3351-3355.
57. Tan P, Shore A, Leary P, Keystone EC 1984 Interleukin abnormalities in recently active rheumatoid arthritis. J Rheumatol 11:593-596.
58. Fakih H, Baggett B, Holtz G, Tsang K-Y, Lee JC, Williamson HO 1987 Interleukin 1: A possible role in the infertility associated with endometriosis. Fertil Steril 47:213-217.
59. Pacifici R, Rothstein M, Rifas L, Lau KH, Baylink DJ, Avioli LV, Hruska K 1990 Increased monocyte interleukin-1 activity and decreased vertebral bone density in patients with fasting idiopathic hypercalciuria. J Clin Endocrinol Metab 71:138-145.
60. Sambrook PN, Reeve J 1988 Bone disease in rheumatoid arthritis. Clin Sci 74:225-230.
61. Comite F, Delman M, Hutchinson-Williams K, DeCherney AH, Jensen P 1989 Reduced bone mass in reproductive-aged women with endometriosis. J Clin Endocrinol Metab 69:837-842.
62. Ralston SH 1994 Analysis of gene expression in human bone biopsies by polymerase chain reaction: Evidence for enhanced cytokine expression in postmenopausal osteoporosis. J Bone Miner Res 9:883-890.
63. Cohen-Solal ME, Craulet AM, Denne MA, Gueris J, Baylink D, de Vernejoul MC 1993 Peripheral monocyte culture supernatants of menopausal women can induce bone resorption: Involvement of cytokines. J Clin Endocrinol Metab 77:1648-1653.
64. Weusten JJ, Blankenstein MA, Gmelig-Meyling FH, Schuurman HJ, Kater L, Thijssen JH 1986 Presence of estrogen receptors in human blood mononuclear cells and thymocytes. Acta Endocrinol 112:409-414.
65. Gulshan S, McCruden AB, Stimson WH 1990 Estrogen receptor in macrophages. Scan J Immunol 31:691-697.
66. Cutolo M, Accardo S, Villaggio B, Clerico P, Bagnasco M, Coviello DA, Carruba G, lo Casto M, Castagnetta L 1993 Presence of estrogen-binding sites on macrophage-like synoviocytes and CD8+, CD29+, CD45RO+ T lymphocytes in normal and rheumatoid synovium. Arthritis Rheumat 36:1087-1097.
67. Polan ML, Loukides J, Nelson P, Carding S, Diamond M, Walsh A, Bottomly K 1989 Progesterone and estradiol modulate interleukin-1β messenger ribonucleic acid levels in cultured human peripheral monocytes. J Clin Endocrinol Metab 69:1200-1206.
68. Kimble RB, Srivastava S, Bellone CJ, Pacifici R 1996 Estrogen inhibits IL-1 and TNF gene expression in transfected murine macrophagic cells. J Bone Miner Res 11 (Suppl 1): in press.
69. Dinarello CA 1994 The biological properties of interleukin-1. Eur Cytokine Network 5:517-531.
70. Pioli G, Basini G, Pedrazzoni M, Musetti G, Ulietti V, Bresciani D, Villa P, Bacci A, Hughes D, Russell G, Passeri M 1992 Spontaneous release of interleukin-1 and interleukin-6 by peripheral blood monocytes after ovariectomy. Clin Sci 83:503-507.
71. Ralston SH, Russell RGG, Gowen M 1990 Estrogen inhibits release of tumor necrosis factor from peripheral blood mononuclear cells in postmenopausal women. J Bone Miner Res 5:983-988.
72. Matsuda T, Matsui K, Shimakoshi Y, Aida Y, Hukuda S 1991 1-hydroxyethilidene-1, 1-bisphosphonate decreases the postovariectomy-enhanced interleukin 1 production by peritoneal macrophages in adult rats. Calcif Tissue Int 49:403-406.
73. Kaneki M, Nakamura T, Masuyama A, Chen JT, Seimiya Y, Shiraki M, Ouchi Y, Orimo H 1991 The effect of menopause on IL-1 and IL-6 release from peripheral blood monocytes. J Bone Miner Res 6:76 (abstract).
74. Zarrabeitia MT, Riancho JA, Amado JA, Napal J, Gonzales-Macias J 1991 Cytokine production by blood cells in postmenopausal osteoporosis. Bone Miner 14:161-167.
75. Hustmyer FG, Walker E, Yu XP, Girasole G, Sakagami Y, Peacock M, Manolagas SC 1993 Cytokine production and surface antigen expression by peripheral blood mononuclear cells in postmenopausal osteoporosis. J Bone Miner Res 8:51-59.
76. Thompson RC, Dripps DJ, Eisenberg SP 1991 IL-1ra: Properties and uses of an interleukin-1 receptor antagonist. Agents Actions Suppl 35:41-49.
77. Symons JA, Young PR, Duff GW 1995 Soluble type i interleukin 1 (I1-1) receptor binds and blocks processing of I1-1-beta precursor and loses affinity for I1-1 receptor antagonist. Proc Natl Acad Sci USA 92:1714-1718.
78. Burger D, Chicheportiche R, Giri JG, Dayer JM 1995 The inhibitory activity of human interleukin-1 receptor anatgonist is enhanced by type II interleukin-I souble receptor and hindered by type I interleukin-1 souble receptor. J Clin Invest 96:38-41.
79. Hansen MB, Svenson M, Bendtzen K 1990 Human anti-interleukin 1a antibodies. Immunol Lett 30:133-140.
80. Simon JA, Eastgate JA, Duff GW 1990 A soluble binding protein specific for interleukin 1β is produced by activated mononuclear cells. Cytokine 2:190-198.
81. Pottratz ST, Bellido T, Mocharia H, Crabb D, Manolagas S 1994 17β-Estradiol inhibits expression of human interleukin-6 promoter-reporter constructs by a receptor-dependent mechanism. J Clin Invest 93:944-950.
82. Ray A, Prefontaine KE, Ray P 1994 Down-modulation of interleukin-6 gene expression by 17 beta-estradiol in the absence of high affinity DNA binding by the estrogen receptor. J Biol Chem 269:12940-12946.
83. Stein B, Yang MX 1995 Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-kappa-B and C/EBP-BETA. Mol Cell Biol 15:4971-4979.
84. Rickard D, Russell G, Gowen M 1992 Oestradiol inhibits the release of tumour necrosis factor but not interleukin 6 from adult human osteoblasts in vitro. Osteoporosis Int 2:94-102.
85. Chaudhary LR, Spelsberg TC, Riggs BL 1992 Production of various cytokines by normal human osteoblast-like cells in response to interleukin-1β and tumor necrosis factor-a: Lack of regulation by 17β-estradiol. Endocrinology 130:2528-2534.
86. Girasole G, Pedrazzoni M, Giuliani N, Passeri G, Passeri M 1995 Increased serum soluble interleukin-6 receptor levels are induced by ovariectomy, prevented by estrogen replacement, and reversed by alendronate administration. J Bone Miner Res 10:A86.
87. McKane R, Khosla S, Peterson J, Egan K, Riggs BL 1993 Effect of age and menopause on serum interleukin-1β and intereleukin-6- levels in women. J Bone Miner Res 8:162A.
88. Khosla S, Peterson JM, Egan K, Jones JD, Riggs LB 1994 Circulating cytokine levels in osteoporotic and normal women. J Clin Endocrinol Metab 79:707-711.
89. Pacifici R, Carano A, Santoro SA, Rifas L, Jeffrey JJ, Malone JD, McCracken R, Avioli LV 1991 Bone matrix constituents stimulate interleukin-1 release from human blood mononuclear cells. J Clin Invest 87:221-228.
90. Pacifici R, Basilico C, Roman J, Zutter MM, Santoro SA, McCracken R 1992 Collagen-induced release of interleukin 1 from human blood mononuclear cells: Potentiation by fibronectin binding to the alpha 5 beta 1 integrin. J Clin Invest 89:61-67.
91. Routtenberg A 1995 Knockout mouse fault lines [letter]. Nature 374:314-315.
92. Poli V, Balena R, Fattori E, et al. 1994 Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion. EMBO J 13:1189-1196.
93. Kimble RB, Matayoshi AB, Vannice JL, Kung VT, Williams C, Pacifici R 1995 Simultaneous block of interleukin 1 and tumor necrosis factor is required to completely prevent bone loss in the early post-ovariectomy period. Endocrinology 136:3054-3061.
94. Kimble RB, Matayoshi AB, Vannice JL, Pacifici R 1994 Long-term treatment with IL-1 receptor antagonist (IL-1ra) blocks bone loss in ovariectomized rats. J Bone Miner Res 9 (Suppl 1): B380 (abstract).
95. Kimble RB, Bain SD, Kung V, Pacifici R 1995 Inhibition of IL-6 activity is genetically normal mice does not prevent ovariectomy-induced bone loss. J Bone Miner Res 10(Suppl 1):s160.
96. Ammann P, Garcia I, Rizzoli R, Meyer JM, Vassali P, Bonjour JP 1995 Transgenic mice expressing high levels of soluble tumor necrosis factor receptor-1 fusion protein are protected from bone loss caused by estrogen deficiency. J Bone Miner Res 10 (Suppl 1):(abstract 1).
97. Wronski TJ, Dann LM, Qi H, Yen CF 1993 Skeletal effects of withdrawal of estrogen and diphosphonate treatment in ovariectomized rats. Calcif Tissue Int 53:210-216.
98. Kimble RB, Vannice JL, Brownfield C, Pacifici R 1994 Persistent bone-sparing effect of interleukin-1 receptor antagonist: A hypothesis on the role of IL-1 in ovariectomy induced bone loss. Calcif Tissue Int 55:260-265.
99. Miyaura C, Kusano K, Masuzawa T, Chaki O, Onoe Y, Aoyagi M, Sasaki T, Tamura T, Koishihara Y, Ohsugi Y, Suda T 1995 Endogenous bone-resorbing factors in estrogen deficiency: Cooperative effects of IL-1 and IL-6. J Bone Miner Res 10:1365-1373.